Curt I. Civin

11.9k total citations · 2 hit papers
202 papers, 9.3k citations indexed

About

Curt I. Civin is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Curt I. Civin has authored 202 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Hematology, 90 papers in Molecular Biology and 43 papers in Immunology. Recurrent topics in Curt I. Civin's work include Acute Myeloid Leukemia Research (40 papers), Hematopoietic Stem Cell Transplantation (39 papers) and Immune Cell Function and Interaction (23 papers). Curt I. Civin is often cited by papers focused on Acute Myeloid Leukemia Research (40 papers), Hematopoietic Stem Cell Transplantation (39 papers) and Immune Cell Function and Interaction (23 papers). Curt I. Civin collaborates with scholars based in United States, United Kingdom and France. Curt I. Civin's co-authors include Michael R. Loken, Matthew Malehorn, Stephen B. Baylin, Robert W. Georgantas, Lewis C. Strauss, Saul J. Sharkis, Linzhao Cheng, Jonathan K. Alder, Sebastien Morisot and G. David Roodman and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Curt I. Civin

200 papers receiving 9.1k citations

Hit Papers

The translocation t(8;16)... 1996 2026 2006 2016 1996 2003 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Curt I. Civin United States 49 4.9k 3.4k 2.0k 1.7k 1.4k 202 9.3k
Arinobu Tojo Japan 45 3.1k 0.6× 2.5k 0.7× 1.9k 1.0× 1.6k 0.9× 1.4k 1.0× 364 8.2k
Bryan D. Young United Kingdom 61 5.2k 1.1× 1.9k 0.5× 1.6k 0.8× 900 0.5× 1.2k 0.8× 191 9.2k
Hiromi Iwasaki Japan 45 4.3k 0.9× 3.5k 1.0× 1.7k 0.9× 3.7k 2.2× 1.1k 0.8× 170 9.1k
D. Robert Sutherland Canada 41 2.5k 0.5× 3.1k 0.9× 1.5k 0.8× 2.3k 1.3× 1.2k 0.9× 97 7.3k
Giao Hangoc United States 46 3.0k 0.6× 3.4k 1.0× 3.2k 1.6× 3.0k 1.8× 1.4k 1.0× 115 8.6k
Andre C. Schuh Canada 35 4.9k 1.0× 2.5k 0.7× 1.4k 0.7× 868 0.5× 947 0.7× 181 7.8k
Edward F. Srour United States 43 2.9k 0.6× 3.0k 0.9× 1.8k 0.9× 2.0k 1.2× 1.5k 1.1× 165 7.2k
Sérgio Dias Portugal 37 5.9k 1.2× 2.0k 0.6× 2.9k 1.5× 1.4k 0.9× 1.4k 1.0× 86 9.7k
Yasuhide Hayashi Japan 45 4.1k 0.8× 2.9k 0.8× 917 0.5× 604 0.4× 727 0.5× 226 7.1k
CI Civin United States 37 2.4k 0.5× 3.1k 0.9× 1.2k 0.6× 2.5k 1.5× 1.2k 0.8× 63 6.9k

Countries citing papers authored by Curt I. Civin

Since Specialization
Citations

This map shows the geographic impact of Curt I. Civin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Curt I. Civin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Curt I. Civin more than expected).

Fields of papers citing papers by Curt I. Civin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Curt I. Civin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Curt I. Civin. The network helps show where Curt I. Civin may publish in the future.

Co-authorship network of co-authors of Curt I. Civin

This figure shows the co-authorship network connecting the top 25 collaborators of Curt I. Civin. A scholar is included among the top collaborators of Curt I. Civin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Curt I. Civin. Curt I. Civin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kingsbury, Tami J., et al.. (2019). Regulation of cancer stem cell properties by SIX1, a member of the PAX-SIX-EYA-DACH network. Advances in cancer research. 141. 1–42. 27 indexed citations
3.
Sasaki, Takayo, Juan Carlos Rivera‐Mulia, Daniel L. Vera, et al.. (2017). Stability of patient-specific features of altered DNA replication timing in xenografts of primary human acute lymphoblastic leukemia. Experimental Hematology. 51. 71–82.e3. 21 indexed citations
4.
Cao, Cheng, et al.. (2016). MIM regulates the trafficking of bone marrow cells via modulating surface expression of CXCR4. Leukemia. 30(6). 1327–1334. 17 indexed citations
5.
Muvarak, Nidal, Carine Robert, Maria R. Baer, et al.. (2015). c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias. Molecular Cancer Research. 13(4). 699–712. 54 indexed citations
6.
Huang, Tai‐Chung, Santosh Renuse, Sneha M. Pinto, et al.. (2014). Identification of miR-145 targets through an integrated omics analysis. Molecular BioSystems. 11(1). 197–207. 21 indexed citations
7.
Ramalingam, Sivaprakash, Karthikeyan Kandavelou, Liudmila Cebotaru, et al.. (2012). Generation and Genetic Engineering of Human Induced Pluripotent Stem Cells Using Designed Zinc Finger Nucleases. Stem Cells and Development. 22(4). 595–610. 36 indexed citations
8.
Huang, Cheng Ran Lisa, A.M. Schneider, Tejasvi Niranjan, et al.. (2010). Mobile Interspersed Repeats Are Major Structural Variants in the Human Genome. Cell. 141(7). 1171–1182. 197 indexed citations
9.
Bohana‐Kashtan, Osnat, Sebastien Morisot, Richard Hildreth, et al.. (2009). Selective Reduction of Graft-versus-Host Disease-Mediating Human T Cells by Ex Vivo Treatment with Soluble Fas Ligand. The Journal of Immunology. 183(1). 696–705. 25 indexed citations
10.
Alder, Jonathan K., Robert W. Georgantas, Richard Hildreth, et al.. (2008). Kruppel-Like Factor 4 Is Essential for Inflammatory Monocyte Differentiation In Vivo. The Journal of Immunology. 180(8). 5645–5652. 169 indexed citations
11.
Yu, Xiaobing, Jonathan K. Alder, Jong Ho Chun, et al.. (2006). HES1 Inhibits Cycling of Hematopoietic Progenitor Cells via DNA Binding. Stem Cells. 24(4). 876–888. 93 indexed citations
12.
D’Costa, Jenice, et al.. (2005). CBFβ-SMMHC slows proliferation of primary murine and human myeloid progenitors. Leukemia. 19(6). 921–929. 13 indexed citations
13.
Georgantas, Robert W., Matthew Malehorn, Shelly Heimfeld, et al.. (2004). Microarray and Serial Analysis of Gene Expression Analyses Identify Known and Novel Transcripts Overexpressed in Hematopoietic Stem Cells. Cancer Research. 64(13). 4434–4441. 98 indexed citations
14.
15.
Yang, Yandan, et al.. (2002). TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice.. PubMed. 62(14). 3904–8. 75 indexed citations
16.
Mason, David Y., Pascale André, Armand Bensussan, et al.. (2001). CD antigens 2001. International Immunology. 13(9). 1095–1098. 15 indexed citations
17.
Trischmann, Thomas M., K G Schepers, & Curt I. Civin. (1993). Measurement of CD34 + Cells in Bone Marrow by Flow Cytometry. Journal of Hematotherapy. 2(3). 305–313. 32 indexed citations
18.
Graham, Michael L., Andrew M. Yeager, Brigid G. Leventhal, et al.. (1992). Treatment of recurrent and refractory pediatric solid tumors with high-dose busulfan and cyclophosphamide followed by autologous bone marrow rescue.. Journal of Clinical Oncology. 10(12). 1857–1864. 10 indexed citations
19.
Civin, Curt I., et al.. (1986). AN ANALYSIS OF IMMUNOLOGICAL PHENOTYPES OF HISTIOCYTOSIS-X CELL - A FEASABILITY STUDY FOR PEDIATRIC ONCOLOGY GROUP. Data Archiving and Networked Services (DANS). 14 indexed citations
20.
Brovall, Charlotte, et al.. (1983). Acute myelofibrosis in a child. The Journal of Pediatrics. 103(1). 91–93. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026